Results

Total Results: over 10,000 records

Showing results for "drug".

361. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/37347/psn-pdf
     March 28, 2012 - Recognition and management of potential drug-drug interactions in patients on internal medicine wards … Recognition and management of potential drug-drug interactions in patients on internal medicine wards … https://psnet.ahrq.gov/issue/recognition-and-management-potential-drug-drug-interactions-patients- internal-medicine-wards … study describes an educational intervention designed to improve the management of clinically relevant drug-drug … https://psnet.ahrq.gov/issue/recognition-and-management-potential-drug-drug-interactions-patients-internal-medicine-wards

362. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/42466/psn-pdf
     March 04, 2015 - Adherence to drug–drug interaction alerts in high-risk patients: a trial of context-enhanced alerting … Adherence to drug-drug interaction alerts in high-risk patients: a trial of context- enhanced alerting … https://psnet.ahrq.gov/issue/adherence-drug-drug-interaction-alerts-high-risk-patients-trial-context- … enhanced-alerting This randomized controlled trial found that tailoring drug–drug interaction alerts … https://psnet.ahrq.gov/issue/adherence-drug-drug-interaction-alerts-high-risk-patients-trial-context-enhanced-alerting

363. Eliminating insulin errors: RPhs share tricks.  | PSNet
     psnet.ahrq.gov/issue/eliminating-insulin-errors-rphs-share-tricks
     June 13, 2011 - Drug Topics. March 20, 2006. … Drug Topics. March 20, 2006. … June 13, 2011 High-priority drug-drug interaction clinical decision support overrides … May 20, 2020 Drug-drug interactions and prescription appropriateness at hospital discharge … April 21, 2021 Improving the specificity of drug-drug interaction alerts: can it be done

364. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/37187/psn-pdf
     September 25, 2008 - Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. … Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. … https://psnet.ahrq.gov/issue/serious-adverse-drug-events-reported-food-and-drug-administration-1998- … https://psnet.ahrq.gov/issue/serious-adverse-drug-events-reported-food-and-drug-administration-1998-2005 … https://psnet.ahrq.gov/issue/serious-adverse-drug-events-reported-food-and-drug-administration-1998-

365. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/35138/psn-pdf
     July 10, 2008 - Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002. … Adverse drug event surveillance and drug withdrawals in the United States, 1969- 2002: the importance … https://psnet.ahrq.gov/issue/adverse-drug-event-surveillance-and-drug-withdrawals-united-states-1969- … Food and Drug Administration (FDA). … https://psnet.ahrq.gov/issue/adverse-drug-event-surveillance-and-drug-withdrawals-united-states-1969-

366. Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine. | PSNet
     psnet.ahrq.gov/issue/benzocaine-sprays-marketed-under-different-names-including-hurricaine-topex-and-cetacaine
     December 02, 2015 - Food and Drug Administration; FDA; CDER; Center for Drug Evaluation and Research. … Food and Drug Administration; FDA; CDER; Center for Drug Evaluation and Research. … October 3, 2017 Overall performance of a drug-drug interaction clinical decision support … April 13, 2022 High-priority drug-drug interaction clinical decision support overrides … A proposed rule by the Food and Drug Administration.

367. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/41789/psn-pdf
     September 01, 2016 - Drug–drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic … Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic … https://psnet.ahrq.gov/issue/drug-drug-interactions-should-be-non-interruptive-order-reduce-alert-fatigue … Alert fatigue is particularly common in drug–drug interaction (DDI) alerts, with prior studies reporting … https://psnet.ahrq.gov/issue/drug-drug-interactions-should-be-non-interruptive-order-reduce-alert-fatigue-electronic

368. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/842430/psn-pdf
     September 05, 2018 - The Safety of Intravenous Drug Delivery Systems: Update on Current Issues Since the 2009 Consensus … The Third Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems convened … in 2018 to evaluate the progress of intravenous (IV) drug safety since the 2009 conference. … At the conference, the two most significant threats to IV drug safety were drug shortages and lack of … The panel developed 10 overarching statements regarding safe IV drug safety including developing and

369. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/46917/psn-pdf
     April 18, 2018 - Consumer mobile apps for potential drug–drug interaction check: systematic review and content analysis … Consumer Mobile Apps for Potential Drug-Drug Interaction Check: Systematic Review and Content Analysis … https://psnet.ahrq.gov/issue/consumer-mobile-apps-potential-drug-drug-interaction-check-systematic- … This study found that available mobile applications that enable patients to check for drug–drug interactions … https://psnet.ahrq.gov/issue/consumer-mobile-apps-potential-drug-drug-interaction-check-systematic-review-and-content

370. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/44406/psn-pdf
     December 04, 2016 - Drug manufacturers' delayed disclosure of serious and unexpected adverse events to the US Food and Drug … Drug Manufacturers' Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug … https://psnet.ahrq.gov/issue/drug-manufacturers-delayed-disclosure-serious-and-unexpected-adverse- events-us-food-and-drug … https://psnet.ahrq.gov/issue/drug-manufacturers-delayed-disclosure-serious-and-unexpected-adverse-events-us-food-and-drug … https://psnet.ahrq.gov/issue/drug-manufacturers-delayed-disclosure-serious-and-unexpected-adverse-events-us-food-and-drug

371. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49790/psn-pdf
     April 01, 2017 - The NICE guideline for drug allergy states that when a patient presents with a suspected drug allergy … contacts and whenever a drug is prescribed, dispensed, or administered.(1) Wherever possible, drug … and adverse drug reactions. … or drug groups to avoid. … Drug allergy: diagnosis and management of drug allergy in adults, children and young people.

372. JCAHO tightens leash on medication reconciliation. | PSNet
     psnet.ahrq.gov/issue/jcaho-tightens-leash-medication-reconciliation
     April 12, 2006 - Drug Topics. March 20, 2006. … Drug Topics. March 20, 2006. … April 12, 2006 High-priority drug-drug interaction clinical decision support overrides … May 20, 2020 Drug-drug interactions and prescription appropriateness at hospital discharge … April 21, 2021 Improving the specificity of drug-drug interaction alerts: can it be done

373. Patient Allergies and Electronic Health Records | PSNet
     psnet.ahrq.gov/web-mm/patient-allergies-and-electronic-health-records
     August 21, 2005 - The NICE guideline for drug allergy states that when a patient presents with a suspected drug allergy … contacts and whenever a drug is prescribed, dispensed, or administered.( 1 ) Wherever possible, drug … and adverse drug reactions. … or drug groups to avoid. … Drug allergy: diagnosis and management of drug allergy in adults, children and young people.

374. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/41700/psn-pdf
     December 31, 2014 - High-priority drug–drug interactions for use in electronic health records. … High-priority drug-drug interactions for use in electronic health records. … https://psnet.ahrq.gov/issue/high-priority-drug-drug-interactions-use-electronic-health-records The … limited by a lack of standardized and tailored alerts to warn prescribing clinicians about dangerous drug–drug … https://psnet.ahrq.gov/issue/high-priority-drug-drug-interactions-use-electronic-health-records https

375. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/40984/psn-pdf
     September 01, 2016 - Provider and pharmacist responses to warfarin drug–drug interaction alerts: a study of healthcare downstream … Provider and pharmacist responses to warfarin drug-drug interaction alerts: a study of healthcare downstream … https://psnet.ahrq.gov/issue/provider-and-pharmacist-responses-warfarin-drug-drug-interaction-alerts- … https://psnet.ahrq.gov/issue/provider-and-pharmacist-responses-warfarin-drug-drug-interaction-alerts-study-healthcare … https://psnet.ahrq.gov/issue/provider-and-pharmacist-responses-warfarin-drug-drug-interaction-alerts-study-healthcare

376. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/45208/psn-pdf
     April 22, 2017 - Cognitive tests predict real-world errors: the relationship between drug name confusion rates in laboratory-based … https://psnet.ahrq.gov/issue/cognitive-tests-predict-real-world-errors-relationship-between-drug-name … Although drug names currently undergo tests to assess their potential for confusion prior to approval … of new drug names. … https://psnet.ahrq.gov/primer/medication-errors-and-adverse-drug-events

377. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/37850/psn-pdf
     June 18, 2008 - Information technology-based approaches to reducing repeat drug exposure in patients with known drug … Information technology-based approaches to reducing repeat drug exposure in patients with known drug … https://psnet.ahrq.gov/issue/information-technology-based-approaches-reducing-repeat-drug-exposure- … https://psnet.ahrq.gov/issue/information-technology-based-approaches-reducing-repeat-drug-exposure-patients-known-drug … https://psnet.ahrq.gov/issue/information-technology-based-approaches-reducing-repeat-drug-exposure-patients-known-drug

378. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/37367/psn-pdf
     May 26, 2011 - Reasons provided by prescribers when overriding drug–drug interaction alerts. … Reasons provided by prescribers when overriding drug-drug interaction alerts. … https://psnet.ahrq.gov/issue/reasons-provided-prescribers-when-overriding-drug-drug-interaction-alerts … 70% of overrides identified in a computerized provider order entry (CPOE) system were for critical drug–drug … https://psnet.ahrq.gov/issue/reasons-provided-prescribers-when-overriding-drug-drug-interaction-alerts

379. Promethazine HCl (marketed as Phenergan) Information. | PSNet
     psnet.ahrq.gov/issue/promethazine-hcl-marketed-phenergan-information
     May 04, 2015 - FDA; Food and Drug Administration; CDER; Center for Drug Evaluation and Research Copy Citation … FDA; Food and Drug Administration; CDER; Center for Drug Evaluation and Research Copy Citation … October 3, 2017 Overall performance of a drug-drug interaction clinical decision support … April 13, 2022 High-priority drug-drug interaction clinical decision support overrides … A proposed rule by the Food and Drug Administration.

380. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/43656/psn-pdf
     September 01, 2016 - Optimization of drug–drug interaction alert rules in a pediatric hospital's electronic health record … Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record … https://psnet.ahrq.gov/issue/optimization-drug-drug-interaction-alert-rules-pediatric-hospitals-electronic … https://psnet.ahrq.gov/issue/optimization-drug-drug-interaction-alert-rules-pediatric-hospitals-electronic-health-record … https://psnet.ahrq.gov/issue/optimization-drug-drug-interaction-alert-rules-pediatric-hospitals-electronic-health-record